|

Why are tech companies buying healthcare companies?

The convergence of healthcare and digital technologies has gained more momentum in recent years as healthcare firms adapt to the changing ecosystem and as big tech companies see the potential in integrating technologies in the medical sector.

The scale of the global digital health market stood at $175.6 billion in 2021, according to Grand View Research, and is estimated to grow at a compound annual growth rate of 27.7% from 2022 through 2030.

The market research firm attributed the anticipated forecast to increasing smartphone penetration, improving internet connectivity and healthcare IT infrastructure, and the rising prevalence of chronic diseases, among other factors.

In the US alone, the size of the digital health market hit $66.5 billion in 2021 from $55.3 billion in 2020.

The COVID-19 effect

As the COVID-19 pandemic took hold, companies have realized the importance of digital transformation in healthcare in terms of diagnosis, medical records tracking, surveillance and other services from transmission of prescriptions to hospital bedside devices for patient monitoring.

However, a study by the National Academy of Medicine published in January found that the pandemic also revealed limitations to digital health technologies including the need for a coherent and accessible data infrastructure to help address the pandemic.

Those limitations still exist even as a number of tech giants have invested heavily in the healthcare sector.

Apple’s focus on health and fitness

Apple (NASDAQ:AAPL), previously the world's most valuable company before it lost the crown to Saudi Aramco, last week underscored its strong presence in the healthcare market with its devices that are “empowering people with their health information.”

The company continues to roll out new updates for the Apple Watch and the iPhone that are focused on health and fitness. This fall, new updates of the iOS and watchOS will center on 17 areas of health and fitness, from heart health and sleep to mobility and women’s health, the company said.

In 2019, Apple CEO Tim Cook said the company’s health offerings will be “Apple's greatest contribution to mankind.”

Amazon’s new healthcare bet

Amazon.com (NASDAQ:AMZN) also has its share of health investments. The e-commerce and tech giant recently disclosed a $3.9 billion plan to acquire One Medical, a chain of primary care clinics in the US, backed by private equity firm Carlyle Group.

The acquisition marks Amazon’s latest investment in the healthcare sector after launching Amazon Care, a virtual health service, in 2019 to treat its employees and their families. The service offers virtual visits, in-person primary care visits and prescription delivery.

Amazon also bought online pharmacy PillPack in 2018 for $753 million. The service, now called Amazon Pharmacy, delivers medications to customers.

Meanwhile, an analysis by The New York Times suggests that Amazon’s purchase of One Medical would provide Amazon access to more data as the target company has 15 years’ worth of medical and health-system data. The deal has so far been met with criticism including from US Senator Amy Klobuchar, who called on the Federal Trade Commission to “thoroughly investigate” the proposed deal due to anticompetitive concerns.

On the other side of the coin, the big tech giants’ efforts to grab a share of the digital healthcare market could be said to improve health systems globally and helps bridge the gap in data sharing, allowing the healthcare and medical sector including drugmakers to fast-track drug development.

“Rising health-care costs and the shift to new payment models in this $4 trillion market will increase the focus on care outside of traditional settings, which will rely heavily on connected technologies,” Bloomberg Intelligence said in an analysis in March.

Author

Mark O’Donnell

Mark O’Donnell

Blackbull Markets Limited

Mark O’Donnell is a Research Analyst with BlackBull Markets in Auckland, New Zealand.

More from Mark O’Donnell
Share:

Editor's Picks

GBP/USD advaces beyond 1.3450 after BoE decision, US Q2 GDP

GBP/USD gains positive momentum on Thursday, surpassing 1.3450 and trading at fresh multi-week highs. The Bank of England decided to maintain the benchmark rate unchanged at 3.75%. The MPC voted 6-3 to keep rates on hold, with the 3 dissenters favoring a rate hike. US Q2 GDP missing expectations helped the pair advance, while renewed US Dollar weakness across the FX board pushed the pair further up ahead of the monthly close.

EUR/USD confortable around 1.1530, highest in six weeks

The EUR/USD pair trades around 1.1530 in the American session on Thursday, reaching fresh six-week highs. The US Dollar is in sell-off mode, with multiple factors weighing on the American currency. Not only did the Federal Reserve vote divided to keep rates on hold on Wednesday, creating doubts about a September hike, but US Q2 GDP missed expectations. A suspected JPY intervention adds pressure on the Greenback.

Gold recovers the $4,100 level as US Dollar weakens further

Gold trades just above $4,100 amid a US Dollar sell-off. The Greenback enjoyed some near-term demand following Wednesday's post-FOMC downfall, but was unable to retain its gains. The preliminary estimate of the US Q2 GDP showed the economy grew at an annual rate of 1.5%, missing the market's expectations of 2.1%.

Bank of Japan set to keep interest rates unchanged after suspected Yen intervention

Investors are turning their attention to the Bank of Japan’s monetary policy announcement on Friday, after the Japanese Yen staged a dramatic rebound during Thursday's American session. The move came amid growing speculation that Japanese authorities intervened in the foreign exchange market after USD/JPY tumbled from above 163.00 to below 158.00 within minutes.

Aave to sunset Sonic, Aptos, zkSync, Scroll reserves, affecting $98 million in supply

Aave is planning to sunset 75 low-activity reserves across its decentralized finance protocol as part of a broader effort to reduce operational, technical and economic risks across its network of deployments.

9-3: Is the Federal Reserve’s vote tally Warsh's new forward guidance?
The rate did not move. Neither did the statement, and that’s the more interesting fact. Set the July 29 Federal Open Market Committee (FOMC) statement beside the one issued on June 17, and the two documents are identical apart from a single verb and a paragraph at the bottom naming three dissenters.